A BioRender Alternative for Researchers Who Make a Few Figures a Month

This page is for researchers and graduate students who make a handful of schematic figures a month — workflows, study designs, conceptual frameworks, simple pathway sketches — and often pay for tools themselves.

Stay on BioRender if:

• you rely on its icon library: cells, organs, organisms and lab equipment drawn by illustrators;
• your lab shares figures, templates and folders, or your institution already pays for it;
• you are making a graphical abstract for an Elsevier journal. Elsevier's policy bars general-purpose AI image tools from graphical abstracts and encourages dedicated illustration tools (details).

In short: free icon libraries cost nothing but time, Mind the Graph is the cheapest subscription, and Vizcept is the cheapest way to pay per figure — if you proofread what it draws. Stay on BioRender if its icon library is the reason you use it.

Prices are the ones each vendor published on 19 September 2026; they change, so check before you buy.

If you are comparing AI-only tools rather than an icon editor, the FigureLabs comparison covers FigureLabs and SciDraw AI, what each one renews at, and which figures are laid out by code.

Three figures a month is 36 a year. Here is what each option costs for that, using the published prices above.

Count tries, not just figures: each Vizcept generation or regeneration uses credits (5 at 2K), while BioRender's paid plans include unlimited figures. Free tools cost time instead of money.

• You describe the figure instead of dragging icons. That is faster for boxes-and-arrows figures and weaker for detailed anatomy.
• You proofread more. Image-model figures can misspell a label or flip an arrow; check every label before you submit (how Vizcept draws figures).
• Editing works differently. In Vizcept you mark the figure and describe the change, or open the SVG in Illustrator or Inkscape. The SVG is traced from the image, so it is not layered icon by icon as in BioRender.
• Journals' AI rules apply. Disclose the tool in the caption; the publisher policy table shows where each publisher wants it.

Here is an example from Vizcept's signaling pathway tool, drawn from a four-sentence description of the MAPK/ERK cascade — growth factor, receptor tyrosine kinase, GRB2 and SOS loading RAS with GTP, then RAF, MEK and ERK into the nucleus.

The cascade order, the compartments and the arrows into the nucleus match the description. But look at RAS: the figure puts a phosphate (P) on it, even though the description said RAS is activated by GTP loading, which is how RAS works. That is the kind of slip an image model makes and a reviewer catches, so read every label against your methods before a figure goes into a paper.

Good fit: figures that are mostly structure and text — conceptual frameworks, study-design flowcharts, PRISMA flow diagrams and experimental workflows — when you'd rather describe them than build them. You own every figure on every plan (publication rights), and a credit pack ends when you're done.

Poor fit: detailed anatomical or molecular illustration where an illustrator-drawn icon library matters; team workspaces; and graphical abstracts for Elsevier journals. If you do make a graphical abstract for another publisher, check its rules first.